Skip to main content
Login
Contact
Subscribe
Search form
Search
The Punxsutawney Spirit
Home
Forms
Delivery Concerns
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Local Guide
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Aileron Therapeutics Inc
(NQ:
ALRN
)
1.930
USD
-0.010 (-0.52%)
Streaming Delayed Price
Updated: 12:34 PM EST, Jan 21, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Aileron Therapeutics Inc
< Previous
1
2
Next >
Thinking about buying stock in Nio, Zomedica, Transenterix, Aileron Therapeutics, or BioNano Genomics?
January 11, 2021
InvestorsObserver issues critical PriceWatch Alerts for NIO, ZOM, TRXC, ALRN, and BNGO.
From
PR Newswire
Aileron Therapeutics Announces Completion of $35.9 Million Registered Direct Offering with Participation by New Fundamental Healthcare Investors Acorn Bioventures, BVF Partners, L.P. and Maven Investm
January 11, 2021
From
GlobeNewswire News Releases
Aileron Therapeutics Announces $35.9 Million Registered Direct Offering
January 06, 2021
From
GlobeNewswire News Releases
Thinking about buying stock in Aileron Therapeutics, Check Cap, Jaguar Health, Clearside Biomedical, or Gritstone Oncology?
January 05, 2021
InvestorsObserver issues critical PriceWatch Alerts for ALRN, CHEK, JAGX, CLSD, and GRTS.
From
PR Newswire
Thinking about buying stock in Pfizer, Senseonics Holdings, AIM ImmunoTech, Aileron Therapeutics, or Microvision?
December 24, 2020
InvestorsObserver issues critical PriceWatch Alerts for PFE, SENS, AIM, ALRN, and MVIS.
From
PR Newswire
Aileron Therapeutics Provides Business Update and Outlines 2021 Strategic Priorities
December 21, 2020
From
GlobeNewswire News Releases
Aileron Therapeutics Reports Third Quarter 2020 Financial Results and Business Highlights
November 12, 2020
From
GlobeNewswire News Releases
Aileron Therapeutics Announces Proof-of-Concept Clinical Data from Ongoing ALRN-6924 Phase 1b Trial Presented in Late-Breaking Presentation at the EORTC-NCI-AACR Annual Symposium
October 24, 2020
From
GlobeNewswire News Releases
Thinking about buying stock in Staffing 360 Solutions, IBM, Selecta Biosciences, 3M, or Aileron Therapeutics?
October 21, 2020
InvestorsObserver issues critical PriceWatch Alerts for STAF, IBM, SELB, MMM, and ALRN.
From
PR Newswire
Aileron Therapeutics to Host Conference Call to Discuss Results from Phase 1b Proof-of-Concept Study of Chemoprotective Therapy ALRN-6924 Being Presented at EORTC-NCI-AACR Annual Symposium
October 20, 2020
From
GlobeNewswire News Releases
Thinking about buying stock in Akebia Therapeutics, Aileron Therapeutics, Riot Blockchain, Plug Power, or Translate Bio?
October 12, 2020
InvestorsObserver issues critical PriceWatch Alerts for AKBA, ALRN, RIOT, PLUG, and TBIO.
From
PR Newswire
Aileron Therapeutics Announces Proof-of-Concept Data for ALRN-6924 to be Featured in Late-Breaking Presentation at EORTC-NCI-AACR Annual Symposium
October 12, 2020
From
GlobeNewswire News Releases
Aileron Therapeutics Announces Common Stock Purchase Agreement for up to $15 Million with Lincoln Park Capital
September 21, 2020
From
GlobeNewswire News Releases
Aileron Therapeutics to Present at Upcoming H.C. Wainwright Virtual Global Investment Conference
September 10, 2020
From
GlobeNewswire News Releases
Thinking about buying stock in Beam Therapeutics, Digital Turbine, Arbutus Biopharma, Aileron Therapeutics, or Snap Inc?
August 06, 2020
InvestorsObserver issues critical PriceWatch Alerts for BEAM, APPS, ABUS, ALRN, and SNAP.
From
PR Newswire
Aileron Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Update
August 05, 2020
From
GlobeNewswire News Releases
Aileron Therapeutics to Present at Two Upcoming Investor Conferences in August
August 03, 2020
From
GlobeNewswire News Releases
Aileron Therapeutics Announces Completion of Enrollment in Dose Optimization Expansion Cohort of Proof-of-Concept Phase 1b Study of ALRN-6924
August 03, 2020
From
GlobeNewswire News Releases
Aileron Therapeutics Initiates Enrollment in Schedule Optimization Part of Phase 1b/2 Study of ALRN-6924 as a Chemoprotection Agent in Small Cell Lung Cancer (SCLC) Patients Being Treated with Topotec
June 29, 2020
From
GlobeNewswire News Releases
Aileron Therapeutics Announces Closing of Public Offering of Common Stock and Exercise of Option to Purchase Additional Shares
June 10, 2020
From
GlobeNewswire News Releases
Aileron Therapeutics Announces Pricing of Public Offering of Common Stock
June 04, 2020
From
GlobeNewswire News Releases
Aileron Therapeutics Announces Proposed Public Offering of Common Stock
June 03, 2020
From
GlobeNewswire News Releases
Thinking about buying stock in Ovid Therapeutics, Celsion Corp, Aileron Therapeutics, Cronos Group, or Bank of America?
June 01, 2020
InvestorsObserver issues critical PriceWatch Alerts for OVID, CLSN, ALRN, CRON, and BAC.
From
PR Newswire
Aileron Therapeutics Announces Positive Interim Results from Phase 1b/2 Clinical Trial of ALRN-6924 for the Prevention of Topotecan-induced Toxicities During Treatment for Small Cell Lung Cancer
June 01, 2020
From
GlobeNewswire News Releases
Thinking about buying stock in PhaseBio Pharmaceuticals, Aileron Therapeutics, JetBlue Airways, Aurora Cannabis, or Remark Holdings?
May 28, 2020
InvestorsObserver issues critical PriceWatch Alerts for PHAS, ALRN, JBLU, ACB, and MARK.
From
PR Newswire
Aileron Therapeutics Announces Initiation of Expansion Cohort and First Patient Enrolled into Expansion Cohort of Phase 1b/2 Study of ALRN-6924 as a Chemoprotection Agent
May 27, 2020
From
GlobeNewswire News Releases
Aileron Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
May 11, 2020
From
GlobeNewswire News Releases
Aileron Therapeutics Announces Plans to Release Interim Results from its Phase 1b/2 Myelopreservation Study in Mid-2020
April 22, 2020
From
GlobeNewswire News Releases
Aileron Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
March 30, 2020
From
GlobeNewswire News Releases
Aileron Therapeutics Announces the Promotion of Richard J. Wanstall to Chief Financial Officer and Treasurer
December 18, 2019
From
GlobeNewswire News Releases
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.